#1 Clinical Trials Search in Europe

Clomipramine Hydrochloride

This article explores the use of Clomipramine Hydrochloride in clinical trials for various conditions. Clomipramine, also known by its brand name Anafranil, has been studied for its effectiveness in treating depression, obsessive-compulsive disorder (OCD), and premature ejaculation. The trials discussed here investigate different aspects of the drug, including its bioavailability, dosage, and efficacy compared to other treatments.

Table of Contents

What is Clomipramine?

Clomipramine Hydrochloride, also known by brand names such as Anafranil, is a medication primarily used to treat various mental health conditions[1]. It belongs to a class of drugs called tricyclic antidepressants, which have been used for many years to treat depression and other related disorders[3].

Conditions Treated

Clomipramine is used to treat several conditions, including:

  • Depression: It is effective in treating various forms of depression[1].
  • Obsessive-Compulsive Disorder (OCD): Clomipramine is widely used and studied for treating OCD, a condition characterized by recurring, unwanted thoughts (obsessions) and/or repetitive behaviors (compulsions)[5].
  • Premature Ejaculation: Some studies have explored its use in treating premature ejaculation in men[3].

Dosage Forms

Clomipramine is available in various forms and dosages:

  • Oral capsules: Typically available in 25 mg strength[1].
  • Intravenous (IV) form: Used in some studies for rapid treatment of OCD[5].
  • Different dosages: Studies have explored various dosages, including 15 mg, 30 mg, and up to 75 mg per day, depending on the condition being treated and individual patient needs[4][6].

How It Works

Clomipramine works by affecting the balance of certain chemicals in the brain, particularly serotonin. Serotonin is a neurotransmitter (a chemical messenger) that plays a crucial role in mood regulation and other mental processes. By increasing the levels of serotonin in the brain, Clomipramine can help alleviate symptoms of depression and OCD[6].

Effectiveness

Research has shown that Clomipramine can be effective in treating various conditions:

  • OCD Treatment: Studies have demonstrated its efficacy in reducing symptoms of OCD, often measured using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)[7].
  • Depression Management: It has been shown to be effective in managing symptoms of depression, particularly in cases of recurrent depression[8].
  • Premature Ejaculation: Some studies have explored its potential in treating premature ejaculation, showing promising results in increasing intravaginal ejaculation latency time (IELT)[3].

Side Effects and Safety

Like all medications, Clomipramine can cause side effects. Common side effects may include:

  • Dry mouth
  • Constipation
  • Blurred vision
  • Drowsiness
  • Weight gain

More serious side effects, though rare, can include changes in heart rhythm. Your doctor will monitor you closely, especially when starting the medication or adjusting the dose. They may perform electrocardiogram (EKG) tests to check for any changes in your heart’s electrical activity[6].

Ongoing Research

Researchers continue to study Clomipramine to better understand its effects and potential uses:

  • Combination Therapies: Studies are exploring the effectiveness of combining Clomipramine with other medications, such as selective serotonin reuptake inhibitors (SSRIs) or antipsychotics like quetiapine, for treating resistant OCD[10].
  • Predictors of Response: Researchers are investigating factors that might predict how well a person will respond to Clomipramine, including genetic markers and specific symptoms of OCD[7].
  • Comparative Studies: Some research compares the effectiveness of Clomipramine to other medications used to treat OCD and depression[8].

It’s important to note that Clomipramine should only be taken under the supervision of a healthcare professional. They will determine the appropriate dosage and monitor your progress to ensure the medication is working effectively and safely for you.

Aspect Details
Conditions Studied Depression, Obsessive-Compulsive Disorder (OCD), Premature Ejaculation
Dosage Forms Oral capsules, tablets, intravenous infusions
Dosage Range 15mg to 250mg, depending on the study and condition
Comparators Placebo, escitalopram, quetiapine, SSRIs
Primary Outcome Measures Y-BOCS for OCD, IELT for premature ejaculation, bioequivalence measures (AUC, Cmax), depression rating scales
Safety Monitoring Side effect scales (e.g., UKU), serotonin syndrome monitoring, EKG for QT interval changes
Study Designs Randomized, double-blind, placebo-controlled, crossover, open-label trials
Additional Assessments Genetic markers, cortical inhibition, quality of life measures

FAQ

  • What conditions is Clomipramine Hydrochloride being studied for in these clinical trials? Clomipramine Hydrochloride is being studied for various conditions, including depression, obsessive-compulsive disorder (OCD), and premature ejaculation.
  • How is Clomipramine Hydrochloride administered in these trials? In the trials, Clomipramine Hydrochloride is administered in various forms, including oral capsules, tablets, and in some cases, intravenous (IV) infusions. The dosages range from 15mg to 250mg, depending on the specific study and condition being treated.
  • What are some of the comparators used in these Clomipramine trials? Some trials compare Clomipramine to placebo, while others compare it to other active treatments such as escitalopram, quetiapine, or SSRIs (Selective Serotonin Reuptake Inhibitors).
  • What are the primary outcomes measured in these clinical trials? The primary outcomes vary depending on the condition being studied. For OCD, the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is often used. For premature ejaculation, the Intravaginal Ejaculation Latency Time (IELT) is measured. Other trials look at bioequivalence based on AUC and Cmax, or changes in depression rating scales.
  • Are there any notable side effects or safety concerns mentioned in these trials? While specific side effects are not detailed in the provided information, some trials mention measuring tolerability and side effects using scales like the Udvalg for Liniske Undersogelser Side Effect Rating Scale (UKU). One study also notes monitoring for serotonin syndrome and changes in EKG regarding QT interval.

Ongoing Clinical Trials on Clomipramine Hydrochloride

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Clomipramine Hydrochloride: A medication belonging to the tricyclic antidepressant class, used to treat various conditions including depression, obsessive-compulsive disorder, and premature ejaculation.
  • Bioavailability: The extent and rate at which a drug enters the body's circulation to produce an active effect.
  • AUC (Area Under the Curve): A measure of the body's drug exposure over time, used to assess bioequivalence between different drug formulations.
  • Cmax: The maximum concentration of a drug in the blood, plasma, or serum after administration.
  • Yale-Brown Obsessive Compulsive Scale (Y-BOCS): A clinical rating scale used to assess the severity of obsessive-compulsive disorder (OCD) symptoms.
  • Intravaginal Ejaculation Latency Time (IELT): The time taken by a man to ejaculate during vaginal penetration, used as a measure in premature ejaculation studies.
  • SSRI (Selective Serotonin Reuptake Inhibitor): A class of antidepressant medications that work by increasing levels of serotonin in the brain.
  • Serotonin Syndrome: A potentially life-threatening condition caused by excessive serotonergic activity in the nervous system, which can occur with certain medications.
  • QT Interval: A measurement on an electrocardiogram (EKG) that represents the time for electrical activation and inactivation of the ventricles of the heart.
  • Cortical Inhibition: A neurophysiological process that regulates brain activity and is thought to be involved in various neurological and psychiatric conditions.

References

  1. https://clinicaltrials.gov/study/NCT00913783
  2. https://clinicaltrials.gov/study/NCT00913952
  3. https://clinicaltrials.gov/study/NCT01439984
  4. https://clinicaltrials.gov/study/NCT01203202
  5. https://clinicaltrials.gov/study/NCT00004310
  6. https://clinicaltrials.gov/study/NCT00564564
  7. https://clinicaltrials.gov/study/NCT01404871
  8. https://clinicaltrials.gov/study/NCT01575158
  9. https://clinicaltrials.gov/study/NCT00254735
  10. https://clinicaltrials.gov/study/NCT00466609